Form 4: Sabra Health Care CFO Granted 39,831 Stock Units

Sabra Health Care REIT's Executive VP, CFO & Treasurer, Michael Lourenco Costa, was granted 39,831 common stock units under the company's performance incentive plan.

Summary

• Michael Lourenco Costa, Executive VP, CFO & Treasurer of Sabra Health Care REIT, Inc. (SBRA), was granted 39,831 stock units.
• The grant occurred on December 31, 2025, under the Issuer's 2009 Performance Incentive Plan.
• These units will vest at a rate of 25% annually on December 31, 2026, December 31, 2027, December 31, 2028, and December 31, 2029.
• Vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock during the 2030 calendar year.
• Earlier payment is possible in the event of separation from service, death, disability, or a change of control.
• Following this transaction, Mr. Costa beneficially owns 395,110 shares directly, which includes 268,068 stock units that will settle into common stock.
• Additionally, Mr. Costa indirectly owns 784 shares via his IRA and 207 shares via his spouse's IRA.

Sentiment

Score: 7

Explanation: The grant of stock units to a key executive is generally a positive signal, indicating management retention and alignment with shareholder interests. It's a routine compensation event, so the impact is moderately positive rather than highly impactful.

Positives

• The grant of stock units aligns the interests of a key executive, Michael Lourenco Costa, with those of shareholders, as his compensation is tied to future company performance and stock value.
• The multi-year vesting schedule (through 2029) promotes long-term retention and commitment from a senior management member.

Future Outlook

The grant of stock units with a multi-year vesting schedule extending through 2029 and payout in 2030 indicates a long-term incentive structure for a key executive, aligning future performance with compensation.

Industry Context

This executive compensation grant is a standard practice in the REIT sector and broader public company landscape, designed to incentivize long-term performance and retain key talent by linking executive wealth to shareholder value creation.

Comparison to Industry Standards

• The structure of this stock unit grant, with a multi-year vesting schedule and a payout tied to common stock, is consistent with typical executive compensation practices observed across the REIT industry and other publicly traded companies. Companies like Ventas (VTR) and Welltower (WELL), also in the healthcare REIT space, frequently utilize similar long-term incentive plans to align management interests with shareholder returns.
• The grant price of $0 for stock units is standard for performance-based or time-based equity awards, reflecting their nature as compensation rather than a purchase.

Stakeholder Impact

• Shareholders: The grant aligns executive incentives with long-term shareholder value, potentially leading to improved company performance.
• Employees: This specific filing pertains to a senior executive's compensation and does not directly detail broader employee impact, though it reflects the company's compensation philosophy for key personnel.

Next Steps

• The stock units will vest in 25% increments on December 31, 2026, 2027, 2028, and 2029.
• Vested units are scheduled for payout in shares of Common Stock during the 2030 calendar year.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation grant and does not present new information that would fundamentally alter the investment thesis for Sabra Health Care REIT. While aligning executive interests with shareholders is positive, it's an expected operational event rather than a catalyst for significant price movement. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals and market conditions.

Keywords

Sabra Health Care REIT, SBRA, Stock Grant, Executive Compensation, Form 4, Insider Transaction, Performance Incentive Plan, REIT